CN105037341A - 阿齐沙坦醇铵晶型及其制备方法 - Google Patents
阿齐沙坦醇铵晶型及其制备方法 Download PDFInfo
- Publication number
- CN105037341A CN105037341A CN201510145421.8A CN201510145421A CN105037341A CN 105037341 A CN105037341 A CN 105037341A CN 201510145421 A CN201510145421 A CN 201510145421A CN 105037341 A CN105037341 A CN 105037341A
- Authority
- CN
- China
- Prior art keywords
- azilsartan
- alcohol
- crystal formation
- formula
- alcohol ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(*)c1cccc2c1*(Cc(cc1)cc(C*(C)(C)CC*)c1-c1ccccc1C(*1=C)=*OC1=O)C(*)=*2 Chemical compound CC(*)c1cccc2c1*(Cc(cc1)cc(C*(C)(C)CC*)c1-c1ccccc1C(*1=C)=*OC1=O)C(*)=*2 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510145421.8A CN105037341B (zh) | 2014-04-04 | 2015-03-30 | 阿齐沙坦醇铵晶型及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410136858 | 2014-04-04 | ||
CN2014101368580 | 2014-04-04 | ||
CN201510145421.8A CN105037341B (zh) | 2014-04-04 | 2015-03-30 | 阿齐沙坦醇铵晶型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105037341A true CN105037341A (zh) | 2015-11-11 |
CN105037341B CN105037341B (zh) | 2019-12-03 |
Family
ID=54444369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510145421.8A Active CN105037341B (zh) | 2014-04-04 | 2015-03-30 | 阿齐沙坦醇铵晶型及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105037341B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105503848A (zh) * | 2014-10-13 | 2016-04-20 | 江苏豪森药业集团有限公司 | 阿齐沙坦有机胺盐复合物及其制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603723A (zh) * | 2011-01-20 | 2012-07-25 | 江苏豪森医药集团有限公司 | 阿齐沙坦有机胺盐及其制备方法和用途 |
CN102548988B (zh) * | 2009-11-30 | 2013-10-23 | 江苏豪森医药集团有限公司 | 阿齐沙坦有机胺盐及其制备方法和用途 |
-
2015
- 2015-03-30 CN CN201510145421.8A patent/CN105037341B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102548988B (zh) * | 2009-11-30 | 2013-10-23 | 江苏豪森医药集团有限公司 | 阿齐沙坦有机胺盐及其制备方法和用途 |
CN102603723A (zh) * | 2011-01-20 | 2012-07-25 | 江苏豪森医药集团有限公司 | 阿齐沙坦有机胺盐及其制备方法和用途 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105503848A (zh) * | 2014-10-13 | 2016-04-20 | 江苏豪森药业集团有限公司 | 阿齐沙坦有机胺盐复合物及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN105037341B (zh) | 2019-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103974949B (zh) | 一种酪氨酸激酶抑制剂的二马来酸盐的i型结晶及制备方法 | |
ES2905973T3 (es) | Proceso para la preparación de diclorhidrato de 5-cloro-N2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-N4-[2-(propano-2-sulfonil)-fenil]-pirimidin-2,4-diamina | |
US20080214633A1 (en) | Alpha-form or beta-form crystal of acetanilide derivative | |
AU2013293973B2 (en) | 4-[5-(Pyridin-4-yl)-1H-1,2,4-Triazol-3-yl]Pyridine-2-Carbonitrile Crystalline Polymorph and Production Method Therefor | |
EP3337485B1 (en) | Crystalline forms of ibrutinib | |
CN104470920A (zh) | 固态形式的维罗菲尼胆碱盐 | |
CN105566327A (zh) | 一种jak激酶抑制剂的硫酸氢盐的i型结晶及其制备方法 | |
CN103864760B (zh) | 一种盐酸法舒地尔化合物 | |
CN103951634A (zh) | 一种依帕司他结晶盐水合物和羟基哌啶共晶物及其制备方法和应用 | |
AU2015342444B2 (en) | Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereof | |
CN104744464B (zh) | 伊曲茶碱晶型 | |
CN105037341A (zh) | 阿齐沙坦醇铵晶型及其制备方法 | |
CN102070605B (zh) | 甲磺酸伊马替尼多晶型物和药用组合物 | |
CA2961819C (en) | L-proline compound of sodium-glucose cotransporter 2 inhibitor, and monohydrate and crystal of l-proline compound | |
CN103382179A (zh) | 英加韦林的多晶型物及其制备方法 | |
CN107827819A (zh) | 一种喷他佐辛晶型及其制备方法 | |
CN111362873B (zh) | 一种加替沙星代谢物的合成方法 | |
CN110194741B (zh) | 4-苯甲酰哌嗪-3-硝基-1,8-萘酰亚胺衍生物及其制备方法和应用 | |
WO2011158255A1 (en) | Process for preparation of stable imatintb mesylate alpha form | |
TWI707851B (zh) | 哌嗪化合物的新穎結晶 | |
CN104788435A (zh) | 一种蛋白酪氨酸激酶抑制剂的二苯磺酸盐的i型结晶 | |
CN104557881A (zh) | 一种盐酸帕唑帕尼晶型的制备方法 | |
EP3704109B1 (en) | Process for the preparation of the crystalline form iii of tipiracil hydrochloride | |
CN110713470B (zh) | 一种盐酸氟桂利嗪晶型b及其制备方法 | |
CN104628588B (zh) | (3-羟基)丙酸基苯胺衍生物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160323 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |